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Abstract
Background: Recruiting children to clinical trials is perceived to be challenging. To identify ways to optimise recruitment
and its conduct, we compared how parents and practitioners described their experiences of recruitment to clinical trials.
Methods and Findings: This qualitative study ran alongside four children’s clinical trials in 11 UK research sites. It compared
analyses of semi-structured interviews with analyses of audio-recordings of practitioner-family dialogue during trial
recruitment discussions. Parents from 59 families were interviewed; 41 had participated in audio-recorded recruitment
discussions. 31 practitioners were interviewed. Parents said little in the recruitment discussions contributing a median 16%
of the total dialogue and asking a median of one question. Despite this, parents reported a positive experience of the trial
approach describing a sense of comfort and safety. Even if they declined or if the discussion took place at a difficult time,
parents understood the need to approach them and spoke of the value of research. Some parents viewed participation as
an ‘exciting’ opportunity. By contrast, practitioners often worried that approaching families about research burdened
families. Some practitioners implied that recruiting to clinical trials was something which they found aversive. Many were
also concerned about the amount of information they had to provide and believed this overwhelmed families. Whilst some
practitioners thought the trial information leaflets were of little use to families, parents reported that they used and valued
the leaflets. However, both parties agreed that the leaflets were too long and wanted them to be more reader-friendly.
Conclusions: Parents were more positive about being approached to enter their child into a clinical trial than practitioners
anticipated. The concerns of some practitioners, that parents would be overburdened, were unfounded. Educating
practitioners about how families perceive clinical trials and providing them with ‘moral’ support in approaching families
may benefit paediatric research and, ultimately, patients.
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Introduction
Clinical trials are essential for evaluating healthcare and
improving treatments for all patient populations. However, most
paediatric specialties have historically had low levels of clinical trial
activity [1,2]. Children have been perceived as a vulnerable
population [3] whose involvement in research should be
minimised in order to protect them and clinical trials in paediatrics
have been regarded as economically unviable, resulting in children
being excluded from the benefits of evidence-based medicine [4].
Gradual realization of the inequities and risks this exclusion posed
to children’s health has led to international policy changes to
augment paediatric clinical trial activity [2,5,6,7]. While these
changes have increased the number of clinical trials being
conducted with children, considerable challenges remain. Poor
accrual is one of the principal reasons for clinical trial failure [8].
Children’s trials may be especially at risk of accrual problems due,
for example, to the relatively small numbers of paediatric patients
with certain diseases and the need to study different age groups
[4]. Concerns about the protection of vulnerable patient popu-
lations, like children, who cannot usually consent for themselves
[4,9,10,11,12,13,14], add to the complexity of recruiting to pae-
diatric trials and continue to drive the promotion of special
safeguards for children’s trials [15].
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Reflecting the history of low clinical trial activity in paediatrics,
most research examining clinical trial recruitment has focussed on
adult trials. But the complexities involved in paediatric trials
mean that lessons from adult clinical trials cannot simply be
extrapolated to children’s trials. Despite the variety of reported
challenges in recruiting children to trials, most paediatric
recruitment research has focussed narrowly on improving
families’ recall and understanding of trials [16,17,18,19]. Such
research is relevant but it cannot tell us what parents and
practitioners themselves consider important about how informa-
tion about clinical trials is communicated and the way that trial
recruitment is conducted [20]. Each party will have unique
perspectives on recruitment. Research which simultaneously
explores and compares their experiences is important to provide
a comprehensive understanding [21] of how recruitment and its
conduct may be improved. Therefore, with the aim of identifying
strategies to improve recruitment and its conduct, this study
compared practitioners’ and parents’ accounts of the invitation to
enter a child into clinical trial.
To explore what was important to participants during trial
recruitment we designed a qualitative study. Because our study
(Processes in recruitment to randomised controlled trials of
medicines for children [short study name, RECRUIT]) focussed
on communication during trial recruitment we designed it to take
account of a fundamental complexity in human communication:
how two people experience and interpret a conversation can differ
markedly from what is evident in their dialogue [22,23,24].
Strategies to improve the experience of clinical trial recruitment
may be misguided or poorly targeted if they are informed by studies
that rely on either dialogue or experience alone. For example,
strategies to improve patient-practitioner communication have
often been based on dialogue without taking account of experiential
data; these have frequently failed to demonstrate improvements that
patients or practitioners recognise [25,26,27,28,29,30,31]. The
reverse - analysing participants’ accounts of their experiences of
communication without reference to their dialogue - is also likely to
be limited [32]. Therefore, we collected both types of data.
Methods
Ethics statement
A UK National Health Service ethics committee gave approval
for the study (Northwest 5 Research Ethics Committee: 07/
MRE08/6). Signed informed consent was obtained from all
participants.
Study design
In this qualitative study, we audio-recorded dialogue during
clinical trial recruitment discussions and interviewed participants
about their experiences of these discussions. In collecting and
triangulating [32] these two sorts of data we aimed to identify
strategies to improve recruitment that took account of both the
‘look’ (the form of communication - what is said) and ‘feel’ (the
meaning of communication - what is experienced) during clinical
trial recruitment.
Study quality
In qualitative research, data triangulation has long been
recognised as important for advancing understanding [33]. In our
study, data triangulation took two forms: ‘data-type’ triangulation
(see previous section) and ‘informant’ triangulation whereby we
compared practitioners’ and parents’ accounts. We describe below
the other procedures [34,35] that we used to ensure the quality and
rigour of our sampling, data collection and analysis.
Sampling of trials
RECRUIT was a ‘research on research’ study that ran
alongside four placebo-controlled randomised clinical trials of
medicines for children. The trials were purposively sampled. All
were public or charity funded trials adopted by the National
Institute for Health Research Medicines for Children Research
Network (MCRN). As such, the trials addressed pressing clinical
questions and avoided obvious design problems that would
adversely impact on recruitment. Our decision to focus on these
trials was also guided by knowing that scarce resource is at stake if
such trials encounter recruitment difficulties. We selected each of
the four trials to represent different conditions, disease status and
trial design to maximise the transferability of findings. The trials
also differed in the timing and circumstances of the approach for
recruitment and in the relationship between family and the
practitioners responsible for recruitment as described in Text S1.
For logistical reasons, we selected sites in the North West of
England where possible. Two or three teams from each trial
facilitated RECRUIT.
Sampling of families and practitioners
Each trial had an initial target to recruit a sub-sample of 15
families to RECRUIT using a mix of consecutive and purposive
sampling. We used consecutive sampling to minimize ‘gatekeeper
bias’ whereby, for example, practitioners might avoid approaching
parents with whom they anticipated communication might be
difficult [36]. We used purposive sampling to access families who
had different trajectories in relation to the trials (i.e. remained on
the trial, were ineligible, declined or withdrew). In particular, as
we neared the target for the MENDS trial, we used purposive
sampling to enrol families who declined MENDS, as our access to
decliners in the wider RECRUIT sample was limited. We accessed
these families after their decision to decline the trial and therefore
no recorded trial discussion was available for them. Sampling of
practitioners was partly tied to the sampling of families in that we
selected those practitioners directly involved in the trial approach
and for whom audio-recordings of trial discussions were available.
However, we also purposely sampled other practitioners who were
likely to have informative experiences of trial recruitment, arising
from their different roles in the four trials or their experience of
other trials. We sampled both doctors and research nurses, as each
profession is closely involved in discussing trials with families in the
UK, and included practitioners who were relatively new to clinical
trial activity, as well as those with more experience.
Recruitment
Practitioners facilitating RECRUIT routinely sought permission
to audio-record trial discussions from families whom they
approached for their respective trials. They described RECRUIT
briefly and asked the families for permission to pass their contact
details to the RECRUIT team. A member of the RECRUIT team
discussed the study in full with the family and sought their consent
to participate further, explaining the RECRUIT team’s indepen-
dence from the trial and clinical team. Audio-recordings of the
trial discussions were retained by practitioners and only released to
the RECRUIT team after the written consent of participants was
obtained. If the family declined RECRUIT, the recorded trial
discussion was erased. Where families were approached without a
recorded trial discussion, the practitioner described the RE-
CRUIT study and asked for permission to pass the family’s contact
details to the RECRUIT team. We sampled in parallel with
analysis until the point when additional data did not alter the
analysis.
Communication about Children’s Clinical Trials
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Interviews
VS and ES conducted in-depth, semi-structured interviews with
parents and practitioners. Interviews were conversational and
responsive to participants, thereby allowing full exploration.
Interview questions were, nevertheless, informed by topic guides
(see Text S2) to ensure core topics were discussed. We initially
based the topic guides on our review of the literature and advice
from steering group members, and developed them over the
course of the study to allow exploration of topics whose
importance became clear as the analysis developed. We also
obtained demographic details from participants. Parents’ post-
codes were used to calculate Index of Multiple Deprivation (IMD)
scores, which are used by UK researchers as indicators of
deprivation in small geographical areas [37]. IMD scores enable
ranking of deprivation in areas based on a combination of domains
comprising income, education, health, housing, services and living
environment [38].
Analysis
We audio-recorded all interviews, transcribed them verbatim,
then checked and anonymised the transcripts. Analysis was
broadly interpretative, and followed the general principles of the
constant comparative method [39,40], cycling between the
developing analysis and new data. We analysed interview
transcripts for evidence of the families’ experiences, needs and
priorities when approached about a trial. For practitioners we
analysed for evidence about their goals in discussing the trials with
families and how they responded to families’ cues. For trial
discussions, we examined the focus of the dialogue, and the types
of questions asked (attending to practitioners’ invitations to elicit
parents’ thoughts and questions about the trial and explore their
understanding) and responses given. We also calculated the
proportion of speech (total utterances spoken by parent/total
utterances spoken) and number of questions asked by parents as
indicators of their ‘observed’ level of interactivity. This allowed us
to compare the ‘look’ of the trial discussion, in terms of parents’
interactivity in the dialogue, with their experience of the ‘feel’ of
the discussion. We also recorded the frequency of practitioners’
use of open and closed questions.
VS led the analysis with assistance from ES, and in consultation
with BY to ensure investigator triangulation [32]. We read
transcripts several times to compare within and between
transcripts, discussing them on numerous occasions to interrogate
the data and explore alternative explanations. Insights from these
discussions were used to develop theoretical categories and ‘test’
the developing analysis. We organised the categories into a
framework to code and index the transcripts using QSR NVivo 8
software. We extracted data relevant to these categories and the
trial approach, whilst interpreting the extracts with reference to
the transcript as a whole, as well as to the proximal content, before
assigning the extracts to the categories and checking their
assignment. We continually reviewed the theoretical categories
in the light of new data, modifying these to ensure they fitted with
the data whilst also accounting for deviant cases. Further
investigator triangulation involved HH, RLS and PRW reviewing
detailed reports of the analysis containing extensive data extracts
and then using their comments to further refine the analysis. We
used respondent validation, whereby we discussed our findings
with practitioner and parent representatives, several of whom were
members of the study steering group. We kept audit-trail records
of the developing analysis, including definitions of the key
theoretical categories. Finally, we examined the quality of the
developing analysis according to its coherence and theoretical
validity, whereby we explored links between our findings and
theoretical ideas in the wider literature [32,34,35].
To evidence our interpretations we present some counts and
percentages for the main categories [41,42], as well as verbatim
extracts from the data. For these extracts, parents’ interviews are
signified by identification codes beginning ‘F’, those from
practitioners beginning ‘P’. For extracts from parent interviews
we indicate whether the family consented, declined, was ineligible
or withdrew from the trials. We signify extracts from parent-
practitioner trial discussions with codes ‘TD’ (followed by parental
identification numbers) and indicate in the text which party is
being quoted.
Results
Participants
We interviewed members of 59 families (58 mothers, 3 fathers).
Figures 1 and 2 illustrate the numbers of families participating in
different elements of RECRUIT by their trajectory in relation to
the trials. Recorded trial discussions were available for 41 of these
families, all of whom completed follow up interviews with the
RECRUIT team. Interviews took place a median of 42 days after
the recorded trial discussion (range 14–126) and lasted approxi-
mately 45 to 60 minutes. We interviewed 48 of the 59 families in
their homes, eight at the trial site and three were telephone
interviews. Of the 33 practitioners approached, we interviewed 31
(94%). 12 were research nurses who were part of the trial teams for
one of the four trials, 14 were doctors who were also members of
the trial teams and five were doctors who regularly recruit to trials
but were not recruiting to any of the four participating trials. The
latter were senior practitioners who responded to an invitation at
one of the participating centres. All practitioners were interviewed
face-to-face in a private room or workspace and their interviews
lasted approximately 45 to 60 minutes. Interviews took place
between March 2008 and January 2010. Table 1 shows parent
demographics and trial participation status for each of the four
trials and breakdown of practitioners by trial.
Interactivity in trial discussions
Parents generally said little during the trial discussions –their
median proportion of speech (total utterances by parent/total
utterances) was 16% (range 1–49%). In 12 discussions parents
contributed 10% or less of the total dialogue, in 16, parents
contributed between 11 and 24% of the dialogue and in 13 they
contributed 25% or more.
The 12 discussions where parents contributed 10% or less of the
dialogue were often the first formal conversation about the trial.
Practitioners systematically presented key trial information in
‘chunks’, which they periodically interspersed with brief closed
questions such as ‘‘alright?’’ or ‘‘okay?’’. Parents mostly responded
with a brief affirmation ‘‘okay’’ ‘‘right’’ ‘‘yeah’’ to confirm that they
understood. For some parents their contributions largely com-
prised such minimal responses. In 6/12 discussions practitioners
invited parents’ comments or questions about the trial on at least
one occasion e.g. ‘‘That’s a lot of information so far. Have you any
questions you want to ask me?’’ (TD42) but not in the remaining six.
Practitioners rarely asked open questions to explore whether the
parent had understood the information.
In the 13 discussions where parents contributed 25% or more of
the dialogue, practitioners’ questions mostly focussed on the child’s
condition and were aimed at establishing eligibility rather than
eliciting parents’ thoughts or questions about the trial or exploring
their understanding (consent was taken after 10/13 discussions). In
6/13 of these ‘high interactivity’ discussions practitioners sought
Communication about Children’s Clinical Trials
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parents’ views of the trial by asking at least one open-ended
question. These were often about the Participant Information
Leaflet (PIL) and occurred at the outset of the discussion ‘‘you’ve had
the information sheets […] what did you think of that when you, you read
through it?’’ (TD18). However, practitioners still tended to use
closed questions to enquire about parents’ understanding of the
trial: ‘‘In a nutshell, does that make sense?’’ (TD3); ‘‘Are you with me so
far?’’ (TD2).
Across all the groups, parents asked few questions during the
recorded trial discussion (median 1, range 0–7). 10 asked no
questions at all, 13 asked only one. Irrespective of the level of
interactivity, practitioners always gave reassurances on trial safety
and commented on the absence of trial procedures that might
distress a child. In this way, practitioners may have pre-empted
parents’ questions, contributing to their relatively low number.
Parents’ experience of verbal and written trial
information
Though parents’ interactivity in the trial discussions was often
low, they did not tell us that they felt inhibited or constrained in
any way. On the contrary, parents often described positive
experiences of the verbal information they had received, and
emphasised their sense of ease in asking questions (see Box 2).
Some explained that they had not asked questions during the trial
discussion because they were happy with the information they had
received ‘‘It was explained the way it was meant to be explained. Anybody
could have understood it’’ (F2 declined) and because they felt
comfortable in contacting the trial team with any questions as
these occurred, ‘‘Most doctors wouldn’t say, ‘Here’s my mobile. Any
worries, just phone me there and then’’’ (F48, ineligible) ‘‘ring her anytime’’
(F36, declined). Indeed, parents described practitioners as
‘‘friendly’’ (F56, consented) ‘‘approachable’’ (F13, consented) ‘‘open
and honest’’ (F51, consented) ‘‘relaxed’’ (F60, consented), ‘‘comfortable
to talk to’’ (F38, declined).
Many parents were mildly critical of the trial PILs, referring to
them in ways that emphasised their length and wordiness: ‘‘It looks
like half a forest’’ (F54, consented). It was not possible to determine
how many parents were deterred from participating in the trials
because of the length and complexity of the PILs but 14/59
parents we interviewed explicitly stated that they personally found
the PIL too long or complicated. A further four commented that
they thought the PILs might be too complex for other parents. A
few parents pointed to information that was absent from the PILs
that they believed to be important, such as the licensing of the trial
medication (F33), how to take trial medication (F16), need for
urine samples (F25), use of non-trial medication (F59) and
Figure 1. Recruitment of families with recorded trial discussion to RECRUIT. Figure pertaining to the recruitment of families to the RECRUIT
study whose trial discussion had been recorded by the trial practitioner facilitating RECRUIT. The families’ trajectory in relation to the trials is shown.
doi:10.1371/journal.pone.0021604.g001
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Figure 2. Recruitment of families approached about RECRUIT who did not have a recorded trial discussion. Figure pertaining to the
recruitment of families to the RECRUIT study where there was no recorded trial discussion with a facilitating practitioner. In all cases, RECRUIT
interviews were conducted after decisions about trial entry and randomisation. The families’ trajectory in relation to the trial is shown.
doi:10.1371/journal.pone.0021604.g002
Table 1. Demographic and trial participation trajectory of parents participating in RECRUIT by individual trial and breakdown of
practitioners by individual trial.
MASCOT MENDS POP TIPIT
N (% of total 59) 10 (17%) 22 (37%) 15 (26%) 12 (20%)
N: Randomised 5 9 13 11
Declined trial 1 81 0 1
Ineligible for trial 4 4 0 0
Withdrawn from trial 0 1 2 0
Median (range) days 35 38 42 52
between recorded trial (30–69) (14–69) (14–119) (20–126)
discussion and RECRUIT interview N= 6 N= 15 N= 8 N=12
Median (range) age of 10 7 13 02
child in years (8–14) (4–13) (4–16)
N (%) not self indentified as white British 0 2 (9%) 1 (6.67%) 6 (50%)
Mean (s.d.) Index of Multiple Deprivation 35.78 44.38 20.344 43.78
score3 (25.06) (24.22) (16.37) (12.20)
Doctors5 2 4 3 5
Research nurses 4 3 4 1
17 of the 8 families who declined MENDS, did so before attending a clinic appointment and as such there are no recorded trial discussions for them. In these instances,
parents were interviewed about their discussions with community paediatricians, telephone conversations with the research nurse and their views on the trial and the
PIL.
2TIPIT is a neonatal trial; hence the median age is 0.
3Higher scores indicate greater deprivation.
4Mean and standard deviation exclude 3 families from Northern Ireland.
5Five doctors were also interviewed who regularly recruited to trials but were not recruiting to the four participating trials.
doi:10.1371/journal.pone.0021604.t001
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eligibility criteria (F5). Despite these problems parents emphasised
how valuable the PILs had been in enabling them to reflect on the
trial in their own time and space. Almost without exception
however parents placed greater value on the face-to-face
discussion than they did on PILs and would not consider
participating in a trial without a personal approach.
If that just came through the door and I didn’t feel it’d got […] any
personal contact, I’d just think, ‘no, I’m not doing it’. (F11,
consented)
Parents’ experience of the trial discussions as a social
encounter
When asked about the recorded trial discussion, rather than
focussing on its informational content parents emphasised their
experience of the discussion as a social encounter and their
experiences of the practitioners. Regardless of their observed level
of interactivity, parents spoke of their sense of comfort during the
discussion, their strong confidence in and liking for the
practitioner, and their sense that the trial was safe and that their
child’s health (rather than the trial) was the practitioner’s
overriding concern. This sense of security was sometimes linked
to the knowledge that the trial was being conducted with the
support of a familiar and trusted clinical team. However, there was
no consistent opinion from parents on whether it was better to be
approached by the child’s regular practitioner or someone who
was not responsible for their child’s clinical care and so was not
known to them. Indeed, parents tended to emphasise the benefit of
whichever ‘model’ they had encountered. Parents also highly
valued practitioners’ consideration and the kindness and commit-
ment of the trial team, particularly their attentiveness to the needs
and preferences of their child (for quotes, see Text S3). We saw few
contrasts between the accounts of parents who declined the trial
and those who consented (Text S4).
Parents’ experiences of the timing of the trial approach
In two of the trials, parents were sometimes approached when
they were fearful for their child’s survival or well-being and it was
not uncommon for these parents to acknowledge that they had
found it difficult to concentrate during the trial discussion. As one
mother approached about the neonatal trial commented, ‘‘it went
sort of like in one ear and out the other […] she was so small and so poorly’’
(F46 consented). However, when asked if the trial discussion could
have been better handled this mother echoed other parents in
remarking:
No, I don’t think so. The doctor was really nice, he was clear and asked
[…] if I had any questions either that day or later […] to speak to
them. (F46 consented)
Although acknowledging the difficulty of discussing a clinical
trial, parents in these distressing circumstances were generally
accepting of the need for research and the need for the approach
to be made. When asked whether she had been approached about
the trial soon after the birth of her son, one mother responded ‘‘the
sooner really you get in there, it’s the better isn’t it?’’ (F9, consented)
Two parents of children with a chronic condition felt that the
timing of the trial approach could have been better ‘‘if they’d given us
even an hour for the diagnosis to sink in’’ (F25, withdrawn) ‘‘it was her first
admission […] I was worried about that’’ (F12, consented). However,
this contrasted with one parent who viewed being approached
when her child was unwell and an inpatient as appropriate
because ‘‘there were a lot more people on hand’’ (F13 consented) to
answer her questions. What mattered for this mother was the
manner of the approach rather than its timing ‘‘I think if they do it in
the right way then it’s okay to approach’’ (F13 consented).
Interestingly, several parents described being ‘‘excited’’ (e.g. F1,
F10, F21) at being asked if their child would participate and
remarked on how ‘‘passionate’’ (F51) and ‘‘enthusiastic’’ (F10)
practitioners were about research. This seemed to inspire parents’
confidence in practitioners’ expertise and commitment. A few
parents described how they would have felt disappointed if they
had not been invited:
You don’t want to think […] there’s some sort of a trial that could
improve your child’s [condition] and your child hasn’t been offered that
[…] I would like to be asked and be given the opportunity to say no.
(F50, ineligible)
Parents also emphasised howmaking a decision about their child at
such a difficult time gave them a sense that they were involved in their
child’s care when there was little else they could do for their child.
A parent needs that little bit of control, just so that they know there is
still something that they’re doing for their child, because other than that
there is nothing. (F29, consented)
Without exception and irrespective of interactivity in the trial
discussion, parents felt that the decision on trial entry was theirs,
said they were satisfied with their decision and that they would
have been able to decline the trial if they had wished.
Practitioners’ experiences of communication with
parents
Practitioners spoke more about the content of trial discussions and
less about their experience of the process as a social encounter than
parents. Practitioners were particularly concerned to ensure that
parents understood the trial and described how the amount and
complexity of information, particularly written information they had
to give parents, undermined this objective. They commented that
PILs were ‘‘not straightforward’’ (P12) ‘‘too long’’ (P2) ‘‘too detailed, too
comprehensive, too busy’’ (P3) and ‘‘too complex’’ (P9). In total 24/31
commented that the leaflets were too long and complex with a further
three stating that although they were happy with the trial PIL they
thought that PILs in general were too complicated. Many
practitioners spoke of how the requirements of ethics guidelines
and committees resulted in PILs which could be ‘‘threatening’’ (P8) or
‘‘overwhelming’’ (P15) for parents and which ‘‘turned people off’’ (P1) or
were not read at all. While practitioners were critical of how current
recommendations shaped PILs, most acknowledged their necessity
and value in communicating about trials and we observed them using
PILs to open and guide the trial discussions. Like parents however,
practitioners valued the face-to-face discussion more highly than the
PILs (Text S5) particularly because face-to-face communication
enabled them to gauge how information was received by parents and
respond to their cues. Practitioners spoke of their concern when
families were eager to agree to the trial when practitioners did not feel
that families had sufficiently understood the trial.
The families I worry about […] are the families that just say, […]
‘it’s all right, I don’t need to read the information sheet. I’m happy,
whatever you say’. (P5)
Communication about Children’s Clinical Trials
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Practitioners described how they felt ‘‘happier’’ (P6) when
families had ‘‘got questions because you feel like they’re wanting to be
fully informed themselves’’ (P6) and commented on how, in the
absence of such feedback, ‘‘it was hard to know whether or not he truly
understood what he was consenting to’’ (P28).
Occasionally practitioners remarked on discussions where they
had annoyed or deterred a parent by continuing to explain the
trial after the parent had said they were happy for their child to
enter the trial ‘‘the fact that they’ve said ‘yes I want to be part of the study’
and you somehow want to argue with them’’ (P1); ‘‘he seemed to be getting
[…] more annoyed with me the more I was talking’’ (P28). This posed a
dilemma for practitioners in making sure parents understood what
they are consenting to, whilst also ensuring that the parent felt
listened to. Other practitioners emphasised how parents’ under-
standing was something that was achieved over time and might
require several discussions. However, some questioned whether
informed consent was achievable at all, particularly when the
child’s condition was critical. They referred to how some parents
could make a decision that they (the parents) were comfortable
with, based on their attitudes to research and on the most essential
information about the trial. They regarded such families’ decisions
not to seek detailed information about the trial as an appropriate
form of autonomy in a stressful situation (Box 4).
A number of practitioners made a clear distinction between
their own particular approach and the ‘required’ content of the
trial discussion as conveyed in programmes such as Good Clinical
Practice (GCP) training ‘‘Oh GCP, but that […] doesn’t teach you how to
talk to people. It just tells you what the rules are really’’ (P28).
These practitioners emphasised the need to be adaptable to the
needs of individual parents.
Giving tips implies that there’s a right and a wrong way of doing it and
I’m not sure that there is, except to be sensitive to different people having
different needs at different times and to listen. (P11)
Practitioners’ comfort with approaching families
Practitioners described different levels and sources of difficulty
in approaching families about trials. The majority did not describe
approaching families as something that they found personally
difficult, but many nevertheless believed that being approached
could exacerbate the emotional impact of the child’s illness ‘‘these
are very, very sick kids […] you’re going up to them and this is yet another
consideration for them’’ (P2). Such concerns were particularly
prominent in the rheumatology and neonatal trials where the
children were often severely or critically ill. Other practitioners
expressed an intense sense of personal disquiet or anxiety about
approaching families about trials ‘‘each parent is different and causes me
great anxiety’’ (P16), ‘‘I will go and approach them but I feel, I feel very
uncomfortable doing it every single time’’ (P18). The primary source of
these practitioners’ discomfort was the intensity of families’ fears
and distress. This led some to ask searching questions about the
morality of approaching such families ‘‘this family’s at a terrible time
and really is it right to be asking them to do this?’’ (P19). Several research
nurses expressed a lack of confidence when working on trials
outside of their specialty and individual practitioners spoke in
strong terms of a range of other difficulties, such as the pressure to
reach recruitment targets (P26), feeling ‘‘like a salesman’’ (P19),
discomfort with children’s medication being selected at random
(P31), and concerns that families’ vulnerability meant they were
liable to be unduly influenced by practitioners (P18). A few
practitioners described how their belief in the importance of
research helped to ease their own discomfort.
Much more stressful for the family and much more stressful for you […]
it’s only because you believe that intervention is critically important to
investigate that you feel that you can kind of carry on (P12)
Occasionally, however practitioners echoed the sentiments of
the parents saying that on the whole, parents did not object to
being approached about research:
The more you recruit people […] you feel less apprehensive yourself
about asking […] you realise that actually asking them and them saying
‘no’, you haven’t upset them. You […] haven’t changed anything. (P28)
Discussion
This study has highlighted a striking disparity between parents’
willingness to be approached about their children’s participation in
clinical trials and practitioners’ discomfort and awkwardness about
recruiting children to the trials. Whether they consented or
declined, no parent objected to being approached about any of the
clinical trials and many described the way the approach was
conducted in highly positive terms. Even in the most difficult
circumstances, parents told us that they understood and accepted
why they were asked and the timing of the approach, providing it
was made in a considerate way. Some even described feeling
excited at being approached about the trial, spoke of how they
valued practitioners’ passion for research, or stated that they
would have been disappointed had they not been asked.
Practitioners did not describe approaching families about trials
in these terms; many regarded trials as an unwelcome burden for
families and some felt personally uncomfortable about approach-
ing families.
Meaning arises in how people experience what is said [43] and
it cannot simply be ‘observed’ in their dialogue [44]. This study
used a novel, multi-perspective design to investigate recruitment in
a way that took account of this fundamental complexity in
communication. It is one of the few studies of trial communication
to do this, accessing its ‘look’ and ‘feel’, and the only study to do so
from the perspectives of both parents and practitioners. Previous
research on the ‘look’ of trial communication has been critical of
how practitioners communicate about trials and encouraged them
to facilitate interactivity [18,45,46,47,48,49]. Interactivity may be
important to facilitate patient understanding of trials [47] but the
‘feel’ of trial communication to both parties cannot be neglected.
In this study parents were positive about practitioners’ commu-
nication despite their low interaction in the trial discussions.
Meanwhile, practitioners described how they sometimes felt
obliged to constrain their explanations to show parents that they
were listening to them. Irrespective of their interactivity parents
felt able to contribute to the discussions and had a sense of
ownership of and satisfaction with their decisions. Therefore, while
parents wanted caring and expert practitioners to explain the trials
to them, they did not necessarily want to actively contribute to the
discussions.
A few families were approached about the trials by their child’s
doctors, although most were approached by practitioners who
were not responsible for the child’s clinical care. This may have
impacted on parental interactivity – parents may have interacted
more if the trial discussions had been initiated by practitioners who
were known to parents and/or could answer questions about their
child’s clinical care. Future research is necessary to investigate
what functions parental interactivity serves during trial discussions
and how it is influenced by the relationship parents have with the
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recruiting practitioner and his/her role in the child’s clinical care.
Similarly, further research would be required to investigate how
practitioners’ comfort in approaching families varies depending on
their relationship with the family. Our interviews with parents and
practitioners indicated that neither had a consistent preference,
rather they were happy with whichever ‘model’ they had
experienced regardless of whether this involved discussing the
trial within or outside an existing clinical relationship [50].
Our inclusion of trials that recruited children who were severely
or critically ill has confirmed that recruitment to such trials is more
challenging for both parties. However, even in these circumstanc-
es, parents did not construe the trial approach as an unwelcome
burden. Other studies have shown that parents are comfortable
with the consent process as a whole [51] and value their
participation in it [52]. Evidence on adult patients’ routine clinical
care has indicated that not all patients want an active role in
discussions with practitioners [53]. More fundamentally, evidence
also indicates that interactivity is not synonymous with a sense of
involvement, and that it is the opportunity to be involved, not
necessarily its enactment that patients value [22,54,55], together
with the sense of being free to accept or decline the practitioner’s
suggestion [44]. Adult patients with cancer and their families
stressed the importance of practitioner communication behaviour
that balances the information content of the discussion with
reflective, supportive and responsive behaviour to support decision
making [56,57]. Our findings offer evidence that the same is true
of parents considering trial entry for their child.
Limitations
This study had some limitations. All practitioners interviewed
were actively engaged in research and only 13/59 families
declined or withdrew from the trials. The divergences that we
found between parents and practitioners could be a reflection of
the relatively small number of declining families in our sample.
However, we identified few differences between parents who
joined the trials and those who declined. A further question is
whether parents were reluctant to directly criticise practitioners
because they were worried that their relationships with practi-
tioners or their child’s clinical care might be affected. We think this
is unlikely for two reasons; firstly we were careful to explain to
families our independence from the trial teams, and secondly a
reluctance to criticise might lead to neutral or mildly positive
accounts rather than the highly positive ones that we observed.
Nevertheless, further research with parents who decline or
withdraw their children from clinical trials is needed.
The time lag between the recorded trial discussions and the
interviews may have led to some details of individual trial discussions
being forgotten. But our aim was to explore participants’ experiences
of the trial approach rather than to test what they could recall of it.
We think that those aspects of the trial approach which participants
focussed upon in their interviews are likely to be indicative of what
they considered important during trial recruitment. Also, we cannot
entirely rule out the possibility that the audio-recording influenced the
trial discussions. However, both audio- and video-recordings have
been extensively used in studies of clinical communication [58,59,60]
and practitioners and patients seem to rapidly habituate to such
recording so that it has little influence on their communication [61].
In any event, 18 parents had not participated in audio-recorded trial
discussions and we found no evidence that experiences of the trial
approach differed, in ways that could be attributed to the audio-
recording, between those parents who had participated in audio-
recorded trial discussions and those who had not.
Mothers predominated in our sample of parents, which
included only three fathers, two of whom were interviewed jointly
with the child’s mother. This reflects parenting norms in UK
society, as well as the relative absence of fathers from the trial
discussions. We were unable to explore the effect of practitioner
gender, which was confounded by profession as all 12 of the nurses
were female while the majority of doctors were male.
Implications for practice
While we used many procedures to ensure this study’s rigour,
quality in qualitative research requires more than procedural
rigour and should also be judged by the insights a study offers to
practice [62,63]. Divergence between the ‘look’ and ‘feel’ of trial
recruitment led us to focus on the social aspects of trial discussions
and the implications for recruitment practice. Previous research
and most recruitment training has highlighted the importance of
procedures aimed at ensuring informed consent, yet our study
indicated how the parent-practitioner relationship and the
everyday norms of clinical care had a crucial role in parents’
experience of their decision. Informed consent procedures are
important, but rigidity in their implementation could interfere
with parents’ sense of involvement and ownership. Parents
emphasised how an environment in which they felt valued and
comfortable to interject was key to how they viewed their
decisions. Many practitioners will recognise the importance of
communicating in ways that foster the right interactional
environment for individual patients [64]. Given the importance
that parents place on the social milieu, it would be a mistake if
recruitment training obstructed practitioners’ discretion and
focussed exclusively on the procedural aspects of informed consent
at the expense of its social norms.
Practitioners were far from complacent about approaching
families about trials. Perhaps linked to their perceptions of
children’s and families’ vulnerability they were particularly
concerned to avoid burdening families. While this conscientious-
ness is broadly reassuring, approaching families seemed arduous
and aversive for some practitioners. Previous research has
focussed on improving patients’ experience of recruitment, but
our findings suggest that diverting some of this effort to improving
practitioners’ experiences of recruitment is also important. Our
findings are directly relevant to the children’s clinical community.
But they also speak to a wider constituency of practitioners –
those who recruit to trials involving other patient groups
perceived as vulnerable, such as trials in emergency medicine
and dementia. If practitioners find recruiting such patients to
trials aversive, some will almost certainly be inclined to avoid
approaching eligible patients. If eligible patients are not
approached it is damaging for research, [10,11,65] and runs
counter to the emphasis on distributive justice in recent guidelines
on research conduct [15,66,67]. Practitioners’ experiences of
recruiting to trials could also leave them demoralised. We suggest
that there is a need for ‘moral support’ or mentoring for
recruiting practitioners and that this should include education
about how families perceive being invited to enter their children
into clinical trials. This may be particularly beneficial for less
experienced practitioners and those working in specialties where
patients and their families are perceived to be particularly
vulnerable.
Finally, parents and practitioners were in agreement that PILs
were too long and complicated and both groups would like to see
these documents be made more reader-friendly. These findings
add to the growing body of literature indicating that regulatory
guidelines are leading to PILs that are at odds with the
requirements of families and practitioners and may even be
damaging to families’ understanding [68] [69].
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